SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCranswick Regulatory News (CWK)

Share Price Information for Cranswick (CWK)

Share Price is delayed by 15 minutes
Get Live Data
5,640.00    -10.00 (-0.18%)
Bid:
5,640.00
Ask:
5,670.00
Spread: 30.00 (0.532%)
Market Cap: £3.02b
CWK Live PriceLast checked at - London Stock Exchange

Intraday Cranswick Share Chart

3rd Quarter Trading Statement

1 Feb 2008 07:01

Cranswick PLC01 February 2008 Cranswick plc ("Cranswick" or "the Company") - third quarter trading statement Total sales for the Company in the quarter to 31 December 2007 were £158m, anincrease of 18 per cent compared to the same period last year after adjustingfor the impact of the sale of the animal feeds business in May 2007. In the food division, turnover increased by 17 per cent compared with the sameperiod last year, which was pleasing given strong comparatives. Most productcategories showed double digit growth, with sausage and bacon performingparticularly well and benefiting from investment in additional capacity duringthe year. Production of premium bacon from the new factory at Sherburn-in-Elmetcommenced on schedule, enabling the high December demand to be met and baconactivities are currently being consolidated on to this site. Turnover in the pet division, which accounted for 6 per cent of total Companysales in the quarter, was up by 37 per cent following better bird food sales.The aquatics business is now fully operative at Chorleywood following a fire inDecember 2006. There has been significant raw material price inflation in thepet food business, most of which has now been passed on in the finished productprice. During the second half, the food division has suffered from some sales pricedeflation. Furthermore, the industry is experiencing rising input costs in pigmeat, beef and poultry. Whilst Cranswick is benefiting from higher than plannedvolume gains, it is currently proving difficult to pass on the full impact ofrising costs. Discussions on this are ongoing with customers. Assuming acontinuation of current conditions, the impact of these two factors, togetherwith the impact of the fall in the value of sterling on the charcuteriebusiness, is expected to have a modest negative impact on the results to 31March 2008. The Directors expect the effect of these issues in the current yearto be approximately matched by exceptional gains of around £1.8m. Whilst it is disappointing to be experiencing these pressures, which can beexpected to moderate the Company's growth rate, Cranswick is in a very strongposition to capitalise once equilibrium returns to input prices and sellingprices. Our market positions are strong, our plants are well invested, thebusiness is highly cash generative and we have excellent customer relationships. Enquiries: CityRoad Communications Paul Quade 020 7248 8010 (mobile 07947 186694) This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
5th Dec 20232:25 pmRNSDirector/PDMR Shareholding
1st Dec 20231:34 pmRNSDirector/PDMR Shareholding
29th Nov 20239:18 amRNSIssue of Equity
21st Nov 20237:00 amRNSInterim Results
1st Nov 20233:21 pmRNSTotal Voting Rights
30th Oct 20239:09 amRNSHolding(s) in Company
5th Oct 202312:18 pmRNSBLOCK LISTING SIX MONTHLY RETURN
5th Oct 202312:15 pmRNSBLOCK LISTING SIX MONTHLY RETURN
5th Oct 202312:10 pmRNSTotal Voting Rights
12th Sep 20232:06 pmRNSDirector/PDMR Shareholding
12th Sep 20232:05 pmRNSDirector/PDMR Shareholding
12th Sep 20232:03 pmRNSDirector/PDMR Shareholding
12th Sep 20232:02 pmRNSDirector/PDMR Shareholding
4th Sep 202310:30 amRNSTotal Voting Rights
29th Aug 20231:58 pmRNSDirectorate Change
29th Aug 202310:56 amRNSDirector/PDMR Shareholding
1st Aug 202312:16 pmRNSTotal Voting Rights
24th Jul 20235:56 pmRNSResult of AGM
24th Jul 20237:00 amRNSFirst quarter trading statement
3rd Jul 20232:04 pmRNSTotal Voting Rights
3rd Jul 20232:03 pmRNSDirector/PDMR Shareholding
3rd Jul 20231:57 pmRNSDirector/PDMR Shareholding
3rd Jul 20231:56 pmRNSDirector/PDMR Shareholding
14th Jun 20238:21 amRNSHolding(s) in Company
5th Jun 20235:18 pmRNSTotal Voting Rights
1st Jun 20234:08 pmRNSDirector/PDMR Shareholding
23rd May 20237:01 amRNSDirector Appointment and Board Changes
23rd May 20237:00 amRNSPRELIMINARY RESULTS
2nd May 202312:56 pmRNSTotal Voting Rights
19th Apr 20232:44 pmRNSBlock listing Interim Review
19th Apr 20232:43 pmRNSBlock listing Interim Review
5th Apr 20239:00 amRNSAdditional Listing
4th Apr 20239:30 amRNSTotal Voting Rights
22nd Mar 20237:30 amRNSDirectorate Change
20th Mar 20231:38 pmRNSHolding(s) in Company
6th Feb 202310:00 amRNSTotal Voting Rights
2nd Feb 20237:00 amRNSThird quarter trading statement
23rd Jan 20239:30 amRNSAdditional Listing
18th Jan 202312:25 pmRNSTotal Voting Rights
6th Jan 202310:57 amRNSDirector/PDMR Shareholding
3rd Jan 202311:43 amRNSDirector/PDMR Shareholding
22nd Dec 202211:20 amRNSCranswick Scrip Dividend Scheme
2nd Dec 20225:47 pmRNSHolding(s) in Company
2nd Dec 20225:07 pmRNSHolding(s) in Company
29th Nov 20227:30 amRNSDirectorship
25th Nov 20221:48 pmRNSHolding(s) in Company
23rd Nov 20223:09 pmRNSDirector/PDMR Shareholding
22nd Nov 20227:00 amRNSInterim Results
16th Nov 20223:14 pmRNSHolding(s) in Company
3rd Nov 20222:55 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.